Compare Canopy Growth Corp (CGC) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Jones Lang LaSalle Inc — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Jones Lang LaSalle Inc trades at $362.41 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 39.7× Canopy Growth Corp's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | JLL | |
|---|---|---|
Market Cap | $421.10M | $16.72B |
Sector | Health | Real Estate |
52-Week High | $1.92 | $373.24 |
52-Week Low | $0.86 | $280.16 |
Enterprise Value | $378.55M | $19.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.
CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.
JLL trades at $362.74, up 1.51% today and near its 52-week high, with a bullish technical signal supported by a golden cross. The company reported strong Q2 2026 earnings, beating estimates with EPS of $5.26 versus $4.56 expected, driven by leasing and capital markets growth. Revenue reached $26.12B in 2025, with net income margin improving to 3.64%. Operating cash flow surged to $1.19B in 2025, reflecting robust financial health. Analyst consensus is a Buy with a $391.50 price target, indicating potential upside from current levels.
The outlook for JLL remains positive given consistent earnings beats, revenue growth, and strong cash flow generation. Key opportunities include momentum in advisory services and recurring revenue streams. Risks involve economic sensitivity to real estate cycles and competitive pressures. Institutional interest is solid, with firms like Bank of America increasing holdings. The stock's valuation at a P/E of 17.43 appears reasonable relative to growth prospects, supporting a constructive view for investors seeking exposure to commercial real estate services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
